The legal backbone of the COVID Emergency Use Authorization (EUA) was simple: no “adequate, approved, and available” alternative could exist for the intended use. That made vaccines untouchable as long as other therapies were dismissed. Many treatments like ivermectin, zinc, and quercetin, but federal agencies consistently brushed them aside. FDA mocked ivermectin as “horse medicine” and platforms censored any promotion. The result was a stacked deck: the vaccine narrative thrived because every possible rival was undermined. This suppression of alternatives was necessary to preserve the legal scaffolding for EUA status. The tragedy is that people who might have benefitted from early treatment never got the chance.
The studies that “disproved” ivermectin and other generics were often funded, designed, or promoted by the very ecosystem that profited from vaccines. Low doses, late treatment timing, and endpoints too broad to show benefit tilted outcomes from the start. Abstracts were worded carefully: “no statistically significant difference” became the headline, while hints of benefit were downplayed. Meanwhile, large vaccine trials were pushed forward with far shorter testing windows, but were blessed by the same agencies. The money trail tells the story—institutions collecting royalties from mRNA patents had little incentive to validate competitors. Instead, dissenting doctors faced board reviews, professional threats, and censorship. The playing field was never level, because truth and profit pointed in opposite directions.
FDA and FTC issued warning letters to companies marketing off-label COVID remedies, including supplements like zinc and quercetin. Social media platforms, working in lockstep with public health agencies, throttled posts and deleted accounts for even discussing alternatives. Doctors retained legal right to prescribe off-label, but the professional risks grew steep. At the same time, billions in government grants flowed to universities and labs that aligned with the vaccine-first narrative. A false balance emerged: vaccine promotion was rewarded, alternative exploration punished. It’s not that every study was fraudulent, it’s that the guardrails were bent to ensure only one story dominated. That imbalance now stands as a case study in how incentives, money, and censorship can suffocate genuine scientific inquiry.
Proverbs 11:1 warns, “Dishonest scales are an abomination to the Lord, but a just weight is His delight.” We saw dishonest scales in the COVID era: trials tilted, speech curtailed, and money flowing to one side of the ledger. Even if vaccines offered protection for some, the deliberate undermining of alternatives meant patients were denied full choice. That is not science, it’s monopoly. As the EUA protections fall away, the truth must be revisited with open eyes. The American people deserve honest science, not bought-and-paid-for conclusions. Accountability for those who profited while others died should not be optional. It should be the first step toward restoring trust in medicine.
Sources
- FDA warns consumers not to use ivermectin for COVID-19– FDA
https://www.fda.gov/consumers/consumer-updates/why-you-should-not-use-ivermectin-prevent-or-treat-covid-19 - Fifth Circuit allows ivermectin lawsuit against FDA to proceed– Reuters
https://www.reuters.com/legal/government/doctors-ivermectin-lawsuit-against-fda-can-proceed-2023-09-01/ - Cochrane Review: Ivermectin for preventing and treating COVID-19
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015017.pub3/full - NIH Office of Dietary Supplements – Zinc: COVID-19 evidence insufficient
https://ods.od.nih.gov/factsheets/Zinc-Consumer/ - Tunisia RCT on zinc and COVID-19 outcomes– Clinical Nutrition ESPEN
https://pubmed.ncbi.nlm.nih.gov/36350776/
